Serum leptin levels in treatment-naive patients with clinically isolated syndrome or relapsing-remitting multiple sclerosis

Autoimmune Diseases

Volumn 2014, Issue , 2014, Pages

  Evangelopoulos, Maria Eleftheria ^a   Koutsis, Georgios ^a   Markianos, Manolis ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; HORMONE BLOOD LEVEL; HUMAN; LEPTIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; SEX DIFFERENCE; SMOKING;

EID: 84914703145     PISSN: 20900422     EISSN: 20900430     Source Type: Journal    
DOI: 10.1155/2014/486282     Document Type: Article

References (22)

1. Ostlund R. E. Jr., Yang J. W., Klein S., Gingerich R., Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. The Journal of Clinical Endocrinology & Metabolism 1996 81 11 3909 3913 10.1210/jc.81.11.3909 2-s2.0-10344260142
2. Schwartz M. W., Peskind E., Raskind M., Boyko E. J., Porte D. Jr., Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nature Medicine 1996 2 5 589 593 2-s2.0-0029881125 10.1038/nm0596-589
3. Moraes-Vieira P. M., Bassi Ê. J., Araujo R. C., Câmara N. O. S., Leptin as a link between the immune system and kidney-related diseases: leading actor or just a coadjuvant? Obesity Reviews 2012 13 8 733 743 10.1111/j.1467-789X.2012.00997.x 2-s2.0-84864009689
4. Sanna V., Di Giacomo A., La Cava A., Lechler R. I., Fontana S., Zappacosta S., Matarese G., Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. Journal of Clinical Investigation 2003 111 2 241 250 2-s2.0-0037241113 10.1172/JCI200316721
5. Batocchi A. P., Rotondi M., Caggiula M., Frisullo G., Odoardi F., Nociti V., Carella C., Tonali P. A., Mirabella M., Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta. Journal of Neuroimmunology 2003 139 1-2 150 154 10.1016/S0165-5728(03)00154-1 2-s2.0-0038797814
6. Chatzantoni K., Papathanassopoulos P., Gourzoulidou E., Mouzaki A., Leptin and its soluble receptor in plasma of patients suffering from remitting-relapsing multiple sclerosis (MS): in vitro effects of leptin on type-1 and type-2 cytokine secretion by peripheral blood mononuclear cells, T-cells and monocytes of MS patients. Journal of Autoimmunity 2004 23 2 169 177 10.1016/j.jaut.2004.05.007 2-s2.0-8444238121
7. + regulatory T cells. Proceedings of the National Academy of Sciences of the United States of America 2005 102 14 5150 5155 10.1073/pnas.0408995102 2-s2.0-17044381726
8. Frisullo G., Mirabella M., Angelucci F., Caggiula M., Morosetti R., Sancricca C., Patanella A. K., Nociti V., Iorio R., Bianco A., Tomassini V., Pozzilli C., Tonali P. A., Matarese G., Batocchi A. P., The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. Journal of Neuroimmunology 2007 192 1-2 174 183 10.1016/j.jneuroim.2007.08.008 2-s2.0-36749018195
9. Emamgholipour S., Eshaghi S. M., Hossein-nezhad A., Mirzaei K., Maghbooli Z., Sahraian M. A., Adipocytokine profile, cytokine levels and foxp3 expression in multiple sclerosis: a possible link to susceptibility and clinical course of disease. PLoS ONE 2013 8 10 e76555 10.1371/journal.pone.0076555 2-s2.0-84884893573
10. Rotondi M., Batocchi A. P., Coperchini F., Severe disability in patients with relapsing-remitting multiple sclerosis is associated with profound changes in the regulation of leptin secretion. Neuroimmunomodulation 2013 20 6 341 347 10.1159/000353567 2-s2.0-84885091011
11. Polman C. H., Reingold S. C., Edan G., Diagnostic criteria for multiple sclerosis: 2005 Revisions to the "McDonald Criteria" Annals of Neurology 2005 58 6 840 846 10.1002/ana.20703 2-s2.0-28544436950
12. McDonald W. I., Compston A., Edan G., Goodkin D., Hartung H.-P., Lublin F. D., McFarland H. F., Paty D. W., Polman C. H., Reingold S. C., Sandberg-Wollheim M., Sibley W., Thompson A., Van Den Noort S., Weinshenker B. Y., Wolinsky J. S., Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of Neurology 2001 50 1 121 127 10.1002/ana.1032 2-s2.0-0034955141
13. Kurtzke J. F., Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983 33 11 1444 1452 10.1212/WNL.33.11.1444 2-s2.0-0021035886
14. Meier U., Gressner A. M., Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clinical Chemistry 2004 50 9 1511 1525 2-s2.0-4344607526 10.1373/clinchem.2004.032482
15. Gallagher D., Visser M., Sepúlveda D., Pierson R. N., Harris T., Heymsfieid S. B., How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? The American Journal of Epidemiology 1996 143 3 228 239 10.1093/oxfordjournals.aje.a008733 2-s2.0-0030054162
16. Saad M. F., Damani S., Gingerich R. L., Riad-Gabriel M. G., Khan A., Boyadjian R., Jinagouda S. D., El-Tawil K., Rude R. K., Kamdar V., Sexual dimorphism in plasma leptin concentration. Journal of Clinical Endocrinology and Metabolism 1997 82 2 579 584 10.1210/jc.82.2.579 2-s2.0-8044233042
17. Masuzaki H., Ogawa Y., Hosoda K., Glucocorticoid regulation of leptin synthesis and secretion in humans: elevated plasma leptin levels in Cushing's syndrome. The Journal of Clinical Endocrinology & Metabolism 1997 82 8 2542 2547 10.1210/jc.82.8.2542 2-s2.0-8544258847
18. Procaccini C., Jirillo E., Matarese G., Leptin as an immunomodulator. Molecular Aspects of Medicine 2012 33 1 35 45 10.1016/j.mam.2011.10.012 2-s2.0-84655176433
19. Matarese G., di Giacomo A., Sanna V., Lord G. M., Howard J. K., Di Tuoro A., Bloom S. R., Lechler R. I., Zappacosta S., Fontana S., Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. Journal of Immunology 2001 166 10 5909 5916 2-s2.0-0035873418 10.4049/jimmunol.166.10.5909
20. Matarese G., Procaccini C., de Rosa V., The intricate interface between immune and metabolic regulation: a role for leptin in the pathogenesis of multiple sclerosis? Journal of Leukocyte Biology 2008 84 4 893 899 10.1189/jlb.0108022 2-s2.0-54249102288
21. Markianos M., Evangelopoulos M. E., Koutsis G., Davaki P., Sfagos C., Body mass index in multiple sclerosis: associations with CSF neurotransmitter metabolite levels. ISRN Neurology 2013 2013 6 981070 10.1155/2013/981070
22. Stommel M., Schoenborn C. A., Accuracy and usefulness of BMI measures based on self-reported weight and height: findings from the NHANES & NHIS 2001-2006. BMC Public Health 2009 9, article 421 10.1186/1471-2458-9-421 2-s2.0-72949092529